首页|Strategy for Viral Safety Risk Reassessment with Changes in the Manufacturing Process of Recombinant Biotechnology Products

Strategy for Viral Safety Risk Reassessment with Changes in the Manufacturing Process of Recombinant Biotechnology Products

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据

Wenbo Sai、Dongchen Jia、Hao Chen、Wei Wei

展开 >

Center for Drug Evaluation,National Medical Products Administration,Beijing 100076,China

2024

10.1016/j.eng.2023.10.003

工程(英文)

工程(英文)

CSTPCDEI
ISSN：2095-8099
年,卷(期)：2024.32(1)
  • 14